Physician profile
Christopher J Low
NPI 1659523066
$28,988.73
in general payments reported to CMS, 2019-2025
23 companies · $1,056 in 2025
The $1,056 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $1,374 · 2021: $1,529 · 2022: $770 · 2023: $1,027 · 2024: $1,315 · 2025: $1,056.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,398.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $21,698.94 | 2019-2022 | |
| Integra Lifesciences Corporation | $2,018.78 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Abbvie INC. | $1,638.66 | 2023-2025 | |
| Musculoskeletal Transplant Foundation INC. | $704.67 | 2020-2023 | |
| Mentor Worldwide LLC | $402.46 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Baxter Healthcare | $376.58 | 2019 | |
| Axogen | $296.46 | 2019-2023 | Avance Nerve Graft |
| Abiomed | $294.53 | 2024 | Impella |
| Innovation Technologies INC | $279.55 | 2024 | Irrisept |
| Stryker Corporation | $257.78 | 2019-2025 | Molli, Spy-Phi System, Eikon |
| Polynovo North America LLC | $223.62 | 2024-2025 | Novosorb Btm |
| Aroa Biosurgery Incorporated | $137.99 | 2023 | |
| Sientra, INC. | $126.15 | 2022 | |
| Dilon Technologies, INC. | $121.79 | 2023-2024 | Hemoblast Bellows |
| Acelrx Pharmaceuticals, INC. | $103.59 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $69.72 | 2021-2022 | |
| Kerecis Limited | $55.93 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acell, INC. | $38.19 | 2020 | |
| Galderma Laboratories, L.P. | $34.04 | 2020-2023 | |
| Motiva USA, LLC | $31.50 | 2025 | |
| Kci USA, INC. | $30.78 | 2019 | |
| Organogenesis INC. | $26.51 | 2019 | |
| Wright Medical Technology, INC. | $20.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Low listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.